The Burkholderia cepacia complex (Bcc) is a group of Gram-negative opportunistic pathogens causing infections in people with cystic fibrosis (CF). Bcc is highly antibiotic resistant, making conventional antibiotic treatment problematic. The identification of novel targets for antivirulence therapies should improve therapeutic options for infected CF patients. We previously identified that the peptidoglycan-associated lipoprotein ( 
it was shown that between 10% and 20% of E. coli cells express Pal on their surface (Michel et al., 2015) . The non-typeable Haemophilus influenzae Pal homologue P6 also has a dual orientation, being exposed infrequently on the surface, but predominantly oriented towards the periplasmic space (Michel et al., 2013) . Pal can be secreted into the extracellular environment or the bloodstream during infection, contributing to septic shock (Hellman, Roberts, Tehan, Allaire, & Warren, 2002) . E. coli Pal is released into human serum in tight association with LPS, inducing TLR2-mediated cytokine production by macrophages. Pal and LPS synergistically activate macrophages indicating that Pal may play an important role in inflammation and the pathogenesis of sepsis (Liang et al., 2005) . Despite considerable studies in other organisms, the role of Pal in Bcc pathogenesis was not investigated previously. The strong anti-Pal immunogenic response in Bcc colonized CF patients (Shinoy et al., 2013) demonstrates that the protein interacts with the human immune system and suggests a role in pathogenesis. Here, we demonstrate that Bcc Pal is structurally similar to E. coli Pal, possessing the conserved peptidoglycan-binding site. We also developed a targeted Pal deletion mutant in B. cenocepacia and showed that Pal plays a role in virulence in an acute infection model, and it is a potent driver of IL-8 secretion and mediates adhesion to lung epithelial cells.
| RESULTS

| Pal is required for pathogenicity in the Galleria mellonella infection model
The Δpal mutant and B. cenocepacia K56-2 wild-type strains had comparable growth curves in Luria-Bertani (LB) with doubling times of 80 and 90 min, respectively. To investigate if Pal has a role in virulence, the survival of the G. mellonella larvae was evaluated following infection with the Δpal deletion mutant in comparison with K56-2.
Although K56-2 was highly lethal to G. mellonella (LD 50 of 1.66 ± 1.91 at 48 hr), Δpal demonstrated substantially attenuated virulence (88-fold increase in LD50 of 145.5 ± 6; p < .001). The virulence phenotype was partially complemented when the pal gene was encoded on a pDA-12 plasmid (LD 50 of 40 ± 5.7) suggesting that the virulence phenotype may be gene dosage dependent and highlights the complexity of virulence in this model. Purified recombinant B. cenocepacia Pal (Pal Bc ) did not affect larval survival, with 100% of larvae surviving after 72-hr exposure to up to 3 μg (maximum dose allowable based on injection volume) of purified recombinant protein, indicating that this amount of pure Pal is not toxic to the larvae.
Larvae injected with cell-free supernatant (CFS) from Δpal showed reduced survival (60% survival at 72 hr) relative to those injected with CFS from wild type (80% survival at 72 hr), (p < .0001; Figure 1 ). When pal gene expression was reconstituted chromosomally in the Δpal mutant, the CFS from complemented Δpal(pal + ) strain did not affect survival at 72 hr. We conclude that this phenotype reflects impaired outer membrane integrity of Δpal, which allows release of periplasmic proteins and outer membrane vesicles to the external milieu contributing to the enhanced toxicity of the supernatant fraction from this strain. Impaired outer membrane integrity was confirmed by measuring the uptake of the fluorescent dye H33342. A 1.4-fold difference in dye uptake was apparent within 30 min by the Δpal mutant over wild-type K56-2 cells; this difference disappeared in the complemented Δpal(pal + ) strain, and this was sustained for over 90 min (p < .0001, Figure 1c ).
Despite the loss of membrane integrity, the cell shape was not impaired relative to wild type ( Figure S1 ).
| Pal does not affect LPS phenotype but is involved in polymyxin resistance
LPS was isolated from wild type and mutant strains to assess if the Δpal mutant had a defect in O-antigen expression. Comparison of LPS extracts from mutant and wild type on 15% acrylamide gels showed no discernible difference in the LPS electrophoretotypes between the Δpal mutant and wild-type K56-2 (Figure 2a ). This was confirmed by mass spectrometry of the lipid A from wild-type K56-2 and the Δpal mutant ( Figure 2b ) and indicates that the decreased virulence of the mutant was independent of LPS composition. As polymyxin B targets LPS components, the sensitivity of Δpal to polymyxin B was also examined. Wild-type K56-2 was highly resistant to polymyxin B on Mueller Hinton agar (MIC 96 μg/mL), but Δpal was threefold more sensitive (MIC of 32 μg/mL; Figure S2 ). Polymyxin B resistance was restored in the complemented strain Δpal(pal + ), confirming that polymyxin susceptibility was due to the loss of Pal.
These results suggest that despite the lack of apparent differences in LPS the Δpal mutant has compromised outer membrane permeability.
In comparison, there was no difference in susceptibility to either levofloxacin (not shown) or meropenem between the wild type and Δpal mutant ( Figure S2 ).
| B. cenocepacia Pal is a lipoprotein with a conserved peptidoglycan-binding site
Pal Bc is a predicted lipoprotein. Consistent with this, its sequence has a hydrophobic N-terminal lipoprotein signal peptide followed by the LAAC lipobox motif, consistent with proteolytic processing by signal peptidase II during translocation across the cytoplasmic membrane (cleavage site between LAA-C, Figure 3a) . Electron spray MS analysis of purified His-tag Pal Bc showed it has a mass of 22820 ± 5 Da, equivalent to the theoretical mass of Pal Bc with poly-His and the Xpress epitope ( Figures S3 and S4 ). Pal Bc co-purifies with acylated forms, with masses consistent with the palmitoylated (23520 Da), myristoylated (23460 Da) and laurylated forms (23408 Da) all having a DAP residue (190.2) . These were identified in the spectrum with relative abundances as determined by peak height ratios of 5:1:1:0.5 ( Figure S4 ). This is consistent with the recombinant Pal Bc being lipidated at the lipobox in the E. coli BL21Star cells and being expressed as a lipoprotein.
As predicted by the Pfam database, Pal Bc also contains an OmpA domain ( Figure 3 ). Based on these analyses and on secondary structure predictions, we cloned and expressed a truncated form of Palcontaining residues 51 to 170 (Pal 51-170 ), which was amenable to crystallization. Pal 51-170 was monomeric in solution, as evidenced by both size exclusion chromatography and dynamic light scattering (Figure 3b and c) . Circular dichroism spectra show that Pal 51-170 adopts a α-β-conformation (Figure 3d ). Also, thermal unfolding curves, achieved by following the circular dichroism signal at 222 nm as a function of temperature, indicate a stable structure, with melting temperature Tm = 48°C (Figure 3e ). Crystals of Pal 51-170 suitable for X-ray diffraction were obtained using vapor diffusion techniques and belonged to the hexagonal space group P3 2 . The structure was solved by molecular replacement and refined at 2.0 Å (Table 3 ). The structure includes two molecules in the asymmetric unit, with close structural similarity (r.m.s.d. 0.2 Å upon superposition of Cα atoms 52-170).
Consistent with circular dichroism data, the overall structure of each molecule showed an α-β sandwich fold, organized in a helix-strand-helix topology ( Figure 4a ). The analysis of the protein surface revealed a deep cavity (located close to the N-terminal ends of the α-helix α2) whose rear wall is contributed by the side chain of Arg120 (Figure 4b ). Surface conservation computation, carried out with ConSurf (Goldenberg, Erez, Nimrod, & Ben-Tal, 2009 ), showed that the residues forming the cavity, namely, Asp-71, Asp-105, Gly-106, Tyr-112, Asn-113, Arg-120, are highly conserved (Figure 4c ). This conservation indicates a functional (Blair, Kim, & Berg, 1991) .
Analysis of electron density maps showed density blobs that were not associated with protein residues in the Pal 51-170 crystals and not compatible with any molecules from the crystallization medium. This density was interpreted as belonging to a muropeptide fragment;
probably, a fragment of the E. coli peptidoglycan bound to the protein upon lysis and carried through the purification process. Likely, Pal recognizes common features between its physiological substrate in B. cenocepacia and a muropeptide of E. coli, as both species produce DAP-type peptidoglycan. Based on the shape and size of electron density, a DAP molecule was built in each cavity of the two molecules in the asymmetric unit (Figure 4d) . In each molecule, DAP is deeply immersed in the identified cavity ( Figure S5 ) having its carboxylate engaging the guanidinium group of Arg-120 in a bidentate salt bridge.
This carboxylate also forms hydrogen bonds to the main-chain amide protons of Asp-105. Nζ of DAP is H-bonded to the side chain of Asp-105 and the main chain carbonyl oxygen of Arg-106 (Figure 4d ).
Hydrophobic interactions also involve Phe-72 and Arg-106, Leu-116, all highly conserved residues. The maps show further density, not interpretable likely due to high flexibility of the bound muropeptide.
The binding mode of DAP to Pal 51-170 resembles that of OmpA of E. coli (Park et al., 2012) , with a similar structural organization of interacting residues ( Figure S6 ).
The ability of Pal 51-170 to bind muropeptides was confirmed by isothermal titration calorimetry (ITC; Figure 5a 
| Pal Bc stimulates a potent pro-inflammatory response
We previously showed that Pal expressed by B. multivorans and B. cenocepacia stimulates a strong antibody response in infected CF patients (Shinoy et al., 2013) . To determine if Pal also contributes to We used two independent methods, cell lysis, and subsequent plating to determine the colony-forming unit (CFU) per mL attached and confocal microscopy. There was a 2.5-fold reduction in binding of the Δpal mutant relative to K56-2 cells (p = .0189), with host cell attachment being reduced to that of the negative control, E. coli strain NCIB9485. This was confirmed by confocal immunofluorescence microscopy, which showed a 34% reduction in attachment of the Δpal mutant relative to wild-type K56-2 (Figure 7 , p = .0462).
Adhesion was restored to wild-type levels in the Δpal(pal 
| DISCUSSION
The Tol/Pal system was extensively studied in E. coli and is associated with various physiological processes in E. coli including cell wall integrity and constriction of the outer membrane. The Pal C-terminus also shares high homology with OmpA, which is associated with host cell attachment of many pathogens (McClean, 2012; De Mot & Vanderleyden, 1994) . TolB and Pal are poorly conserved proteins, although ubiquitous across Gram-negative organisms; however, they are conserved among Bcc species (Plesa et al., 2004) . Pal is essential for survival and pathogenesis in other bacteria, although its role in virulence was not clearly defined (Godlewska et al., 2009) . We have previously shown that Pal is immunogenic in Bcc colonized CF patients (Shinoy et al., 2013) , but little was known about the role of Pal in Bcc.
In this study, we have demonstrated that the Pal protein from B. cenocepacia plays a role in virulence and mediates host cell attachment.
In addition, we have demonstrated that Pal Bc stimulates IL-8 secretion.
The crystal structure of the OmpA-like domain of Pal Bc revealed strong structural similarities with Pal proteins from B. pseudomallei and E. coli, which form a characteristic α-β sandwich fold (Gourlay et al., 2013) . Further, the Pal Bc structure confirmed its potential to bind peptidoglycan, consistent with the conservation of specific residues that contribute to a deep cavity where the DAP moiety is located. It is likely that peptidoglycan binding plays an important role in anchoring of the outer membrane to the bacterial cell wall and contributing to maintain cell envelope integrity (Park et al., 2012) and may also limit the lateral diffusion of OmpA proteins in outer membranes (Verhoeven, Dogterom, & Den Blaauwen, 2013; Winther, Xu, BergSorensen, Brown, & Oddershede, 2009 ).
Mutations defective in Tol/Pal proteins are not always lethal suggesting that other outer membrane proteins may act as substitutes (Godlewska et al., 2009) . Mutations typically result in hypersensitivity to detergents and/or antibiotics (Cascales, Bernadac, Gavioli, Lazzaroni, & Lloubes, 2002 ) and disruption of cell-envelope integrity (Rodriguez-Herva et al., 1996) , suggesting a role for these proteins in maintaining structure and function of the cell envelope. Consistent with this notion, Pal Bc also has a role in maintaining membrane integrity as determined by the increase in permeability to H33342, which was reversed in the complemented strain. In addition, the enhanced lethality of CFS from the Bcc Δpal strain to G. mellonella compared with
WT is also suggestive of release of virulence factors and/or inflammatory mediators in the mutant. Further, the enhanced sensitivity of Δpal to the membrane-acting antibiotic polymyxin also denotes enhanced outer membrane permeability. Polymyxin binds to LPS, allowing its hydrophobic tail to disrupt both bacterial membranes. Given that the permeability of the mutant is impaired due to the lack of Pal, it is reasonable to assume the mutant would also be more susceptible to the detergent action of the hydrophobic tail. In contrast, no alteration Error bars represent the standard deviation of three independent biological repeats, ***p < .001 relative to wild type (c and d). IL-8 (c) and IL-6 (d) secretion in response to increasing concentrations of Pal Bc (10-100 μg/mL) compared to LPS (100 μg/mL) or medium alone (control). Error bars represent the standard deviation of three independent biological repeats. *p < .05, **p < .01, ***p < .001 relative to the medium-only control in meropenem susceptibility was observed. This is expected, as meropenem inhibits peptidoglycan synthesis and although Pal binds to peptidoglycan; the synthesis of the peptidoglycan layer should remain unimpaired in the Pal mutant, and consequently, both mutant and wild type show similar susceptibilities.
We have used two methods of complementation in these studies, either with a plasmid encoded gene or with a chromosomally encoded gene. We complemented several genes previously via deletion of the efflux pump without any adverse impact on virulence relative to wild type (Andrade & Valvano, 2014; Hamad, Skeldon, & Valvano, 2010; Rosales-Reyes, Aubert, Tolman, Amer, & Valvano, 2012) .
Complementation of membrane proteins using plasmids is difficult due to gene dosage effects and was most likely the reason for partial complementation of the virulence phenotype. We have encountered similar problems in the past when studying the Burkholderia mgtC gene (Maloney & Valvano, 2006) . Lack of full complementation is most likely a gene dosage effect. However, placing the pal gene in the chromosome at an ectopic location may also cause reduced expression. Despite this, we have successfully complemented several of phenotypes in this study using chromosomal complementation, including host cell adhesion, membrane permeability, and antibiotic susceptibility.
Despite reports that the Tol/Pal system has a role in the biogenesis and transport of LPS components in E. coli (Gaspar et al., 2000; Vines et al., 2005) , Pal Bc does not appear to be required for LPS transport, as the Δpal mutant and wild type showed comparable LPS profiles. Given the high degree of modularity that exists in Tol/Pal complex, it is plausible that those individual components in the complex are replaced across evolution and that functional roles associated with one member of the complex in a bacterial species may be carried out by another member of the Tol/Pal complex in other bacteria. conserved surface-exposed epitope in H. ducreyi (Spinola, Wild, Apicella, Gaspari, & Campagnari, 1994) and more recently was reported to be surface expressed in a subpopulation of E. coli cells (Michel et al., 2015) . Given the similarities between Bcc and E. coli 
| Culturing epithelial cells
The CFBE41o − lung epithelial cell line, which is homozygous for the CFTR ΔF508 mutation, the most commonly inherited CF mutation, was a gift from Dr Dieter Gruenert (UCSF California). CFBE41o − cells were maintained in MEM medium with 10% (v/v) FBS, 1% penicillin/ streptomycin, 1% L-glutamine, and 1% non-essential amino acids and incubated in 5% CO₂ environment at 37°C.
| Mutagenesis of B. cenocepacia K56-2 and complementation
Unmarked and non-polar mutations were performed by the protocol of Flannagan, Linn, and Valvano (2008) . The amplicons to construct the mutagenic plasmid were digested with EcoRI-HindIII and HindIII-NheI, respectively, and cloned into pGPI-SceI-2 digested with EcoRI and Table 2 ). The resulting amplicon was digested with NdeI and XbaI and ligated into a similarly digested (Figurski & Helinski, 1979) pDAI-SceI Encodes the ISce-I homing endonuclease, Tet sequence homology between the vector and target genome (Hamad et al., 2010) . As before, pDAISce-I was introduced resulting in the replacement of BCAL1674-1675 by pal. The correct replacement was confirmed by PCR amplification. For virulence studies, the pal gene was also complemented using a plasmid constitutively expressing wild-type K56-2 pal that was constructed by amplifying the gene (primers in Table 2 ). Amplicons were digested with NdeI and XbaI and cloned into a similarly digested pDA12 vector, resulting in pDA12-pal. These complements are designated Δpal(pDA-12pal).
| G. mellonella survival assay
Log-growing bacteria were diluted to OD 600 0.1 in sterile PBS and serially diluted to 10
. Each dilution (20 μL) was injected into the hindmost left proleg of G. mellonella larvae using a sterile Terumo 0.3-mL syringe (10 larvae per group). An equal volume of each dilution was also plated onto LB agar, and plates were counted at 48 hr to accurately quantify bioburden injected. Ten larvae injected with PBS alone served as controls. Larvae were incubated at 37°C and examined for survival at 24, 48, and 72 hr. The % larval survival was plotted against the CFU inoculated value to calculate the LD 50 value for each strain (Costello et al., 2011) . Cell-free supernatants of K56-2 wild type and mutants were also assessed by centrifuging overnight cultures at 2,500 g for 10 min. The supernatants were decanted into a sterile universal and filter-sterilized using a 0.20 μm filter to obtain cell-free supernatant. Aliquots (20 μL) of each supernatant were injected into groups of larvae, and 20 μL of supernatant was also plated onto LB agar to ensure sterility. Ten larvae injected with LB broth alone served as controls. In separate experiments, recombinant purified endotoxin free Pal was also injected into groups of larvae and compared with negative control and with LPS. Larval survival was examined at 24, 48, and 72-hr post-inoculation and % survival relative to LB control group determined each time point.
| Accumulation of fluorescent dye H33342
Cellular permeability was determined by uptake of fluorescent dye 
| Cell shape analysis
Cell shape was examined according to published methods (Shiomi, Sakai, & Niki, 2008) . Cells were grown at 37°C in LB overnight before re-inoculation and culture to achieve log growth (OD 600 of 0.5-0.7).
Optical sectioning was performed with an Olympus FV-10 ASW confocal microscope using a Plan Apo X60 1.40 oil-immersion objective lens and Olympus FLUOVIEW Ver.3.1 software. Section images were captured along the z-axis at 0.2-μm intervals.
| Cloning and expression of Pal Bc
The forward primer was designed to contain the CACC sequence at the beginning of the primer to introduce a 5′ overhang allowing directional cloning of the BCAL3204 (pal) gene into pET100/D-Topo (Thermo Fisher, Paisley, UK; in-frame with a 35-amino acid tag construct containing the N-terminal 6xHis tag and Xpress epitope).
PCR amplification was carried out using HotStar Taq polymerase of 1 mM for 3 hr at 37°C. Bacteria were then pelleted using centrifugation at 2,500 g for 10 min. Supernatants were discarded; pellets weighed and stored at −80°C.
| Pal Bc purification
Purification of Pal Bc was carried out as described by Franken et al. (2000) with some modifications to ensure complete removal of lipopolysaccharide from the preparation. Ice-cold lysis buffer containing 6 M Guanidine-HCL, 100 mM sodium phosphate, 10 mM Tris-HCl (pH 8), and 1X EDTA-free protease inhibitor was added to bacterial pellets at a volume of 30 mL corresponding to 7 g of wet cell pellet.
Cells were resuspended in lysis buffer by vortexing and pipetting and subsequently lysed on ice with a cell disruptor using maximum output for two 30-s pulses. Cell debris and any remaining intact cells were pelleted using centrifugation at 6,300 rpm for 35 min. Supernatants were filtered through a 0.45 μM filter and incubated with a rotating Ni-NTA column, which was pre-equilibrated with buffer A, for 1 hr at 4°C. Unbound protein and endotoxin were removed from the column by a series of washes with 8 M Urea in phosphate buffer, followed by two rounds of organic washes (60% isopropanol in 10 mM Tris HCl) alternating with 10 mM Tris HCl. Bound protein was subsequently eluted with 1% trifluoroacetic acid followed by two additional elution steps in 250 and 300 mM imidazole. After purification, the protein concentration of each fraction was determined using the Bradford assay. Protein purity was determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
Proteins were concentrated using Amicon ® filters with a 3 kDa cutoff, resuspended in 50 mM Tris (pH 7), and tested for endotoxin content by the Limulus amebocyte lysate assay using the ToxinSensor Gel clot endotoxin assay kit (Genscript, New Jersey) according to the manufacturer's instructions. The mass of the intact purified protein was confirmed by Electron spray Mass Spectroscopy (Alta Biosciences, Birmingham, UK).
4.9 | Cloning, expression, and purification of truncated Pal Bioinformatic analyses were carried out using SignalP, LipoP, XtalPred (Jahandideh, Jaroszewski, & Godzik, 2014; Bendtsen, Nielsen, Von Heijne, & Brunak, 2004) . Based on these analyses, the variant with the highest crystallization success rate was a Pal protein lacking the first 50 N-terminal amino acids (Pal 51-170 ). A DNA fragment encoding Pal 51-170 was obtained by PCR amplification (primers shown in Table 2 ).
The amplicon was subcloned into the pETM13 expression system to obtain a C-terminal 6xHis-tag recombinant protein and introduced into Glycerol, 0.01% CHAPS, 10 mM Imidazole, pH 7.5) supplemented with a protease-inhibitor cocktail (Roche Diagnostic). After sonication and subsequent centrifugation at 30,000 g for 30 min, the soluble fraction was purified by affinity chromatography using a 5 mL Ni-NTA column (GE Healthcare). After washing with Binding Buffer (50 mM Tris-HCl, 300 mM NaCl, 5% Glycerol, 0.01% CHAPS, pH 7.5), Pal 51-170 was eluted with a linear gradient of Imidazole (5-300 mM), and the fraction collected was analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. A final purification step by size exclusion chromatography was performed using S75 10/300 (GE Healthcare) column in 50 mM Tris-HCl, 150 mM NaCl, 5% Glycerol, pH 7.5. The eluted fractions were concentrated using Amicon ultra column 
| Sequence conservation analysis
Sequence conservation analysis was carried out using ConSurf (Goldenberg et al., 2009 ). The homologue search algorithm CSI-BLAST was used to retrieve sequences from the UNIREF-90 sequence database using an E-value cutoff of 0.001. Sequences were aligned using MAFFT-L-INS-I alignment method (Katoh & Standley, 2013) . Table 3 . The crystal structure was solved by molecular replacement using the software Phaser (McCoy et al., 2007) , and the structure of acute phase antigen BPSL2765 from B. pseudomallei as a template (Gourlay et al., 2013 ). Crystallographic refinement was first carried out against 95% of the measured data using the CCP4 program suite (Potterton, Briggs, Turkenburg, & Dodson, 2003) . The remaining 5% of the observed data, which were randomly selected, was used in Rfree calculations to monitor the progress of refinement. The structure was validated using PROCHECK (Laskowski, Rullmannn, Macarthur, Kaptein, & Thornton, 1996) . Coordinates and structure factors were deposited with the Protein Data Bank with the PDB code 5LKW. 
| Statistical analysis
Statistical analysis of cytokine release and Bcc attachment to epithelial cells was carried out using one-way ANOVA followed by Bartlett's test, using GraphPad Prism. Comparison of attachment of E. coli BL21 Star cells expressing or not expressing Bc Pal was performed by one-way ANOVA using Minitab software. Comparison of the fluorescent dye accumulation curves was performed by two-way ANOVA using GraphPad Prism. Log-rank test of survival data were performed using the GraphPad Prism software version 6.0 (GraphPad Software, San Diego California) ****p < .001.
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